Patent Oppositions in metabolic drugs industry

Explore the competitive field of metabolic drugs where companies are constantly innovating to stay ahead. Discover the latest patent opposition trends, top companies filing and facing patent oppositions, and the most recent patents under dispute. Stay informed on patent activity in metabolic drugs technology and learn how to protect your intellectual property.

Explore the top companies that have filed the most patent oppositions in the technology industry.

Explore the top companies that have faced the most patent oppositions in the technology industry.

Explore the top law firms that have filed the most patent oppositions in the technology industry.

Patent challenges are becoming increasingly common in the metabolic drugs industry as companies work to protect their innovations in a highly competitive market. These legal battles can significantly impact the development and release of new technologies. Below is a list of the latest patents that have been opposed in the metabolic drugs industry, offering a snapshot of the ongoing struggles over intellectual property rights. For anyone involved in this industry, understanding these patent disputes is essential for navigating its future.

Last updated on: Oct 8, 2026
Patent NumberTitleApplicantOpposition DateOpposition Name
Compositions And Methods Of Treating Lupus NephritisGENENTECHSep 30, 2026KERNEBECK PATENTANWALTS
Compositions And Methods Of Treating Lupus NephritisF HOFFMANN LA ROCHESep 30, 2026MAIWALD PATENTANWALTS
Cytotoxicity-Inducing Therapeutic AgentCHUGAI SEIYAKU KABUSHIKI KAISHASep 29, 2026STRAWMAN
Compositions And Methods Of Treating Lupus NephritisF HOFFMANN LA ROCHESep 29, 2026WUESTHOFF & WUESTHOFF
Compositions And Methods Of Treating Lupus NephritisF HOFFMANN LA ROCHESep 29, 2026WUESTHOFF & WUESTHOFF
Dosage Forms For Tyk2 InhibitorsBRISTOL MYERS SQUIBBSep 24, 2026KERNEBECK PATENTANWALTS
Methods Of Treating Fabry DiseaseAMICUS THERAPEUTICSSep 24, 2026MAIWALD PATENTANWALTS
Lipid Nanoparticle Compositions And Methods For Mrna DeliveryTRANSLATE BIOSep 24, 2026MARGARET DIXON
Dosage Forms For Tyk2 InhibitorsBRISTOL MYERS SQUIBBSep 23, 2026SANDOZ
Lipid Nanoparticle Compositions And Methods For Mrna DeliveryTRANSLATE BIOSep 23, 2026PFIZER

To stay ahead in the competitive metabolic drugs industry, companies are constantly innovating. Here are the top patents facing oppositions in the metabolic drugs industry. Stay informed on the latest opposition trends and learn how to protect your intellectual property.

Last updated on: Oct 8, 2026
Patent NumberPublication DateTitleApplicantTotal Oppositions
Oct 12, 2022S1P Receptor Modulators For Treating Multiple SclerosisNOVARTIS24
Apr 14, 2021Methods And Compositions For Treating CancerJANSSEN ONCOLOGY22
Nov 26, 2025Sglt-2 Inhibitor For Treating Type 1 Diabetes Mellitus, Type 2 Diabete Mellitus, Impaired Glucose Tolerance Or HyperglycemiaBOEHRINGER INGELHEIM19
Jan 17, 2024Pharmaceutical Composition Comprising Glucopyranosyl Diphenylmethane Derivatives, Pharmaceutical Dosage Form Thereof, Process For Their Preparation And Uses Thereof For Improved Glycemic Control In A PatientBOEHRINGER INGELHEIM19
Aug 6, 2025Use Of Long-Acting Glp-1 PeptidesNOVO NORDISK18
Jan 16, 2019(+)-2-[1-(3-Ethoxy-4-Methoxyphenyl)-2-Methylsulfonylethyl]-4-Acetylaminoisoindoline-1,3-Dione: Methods Of Using And Compositions ThereofAMGEN EUROPE15
Sep 17, 2025Methods Of Treating Chronic Kidney Disease With DapagliflozinASTRAZENECA14
Mar 10, 2021Novel Antitumoral Use Of CabazitaxelSANOFI13
Nov 21, 2018Formulation Of Boronic Acid CompoundsTHE UNITED STATES OF AMERICA11
Nov 2, 2016Multiple-Variable Dose Regimen For Treating Tnfalpha-Related DisordersABBVIE BIOTECHNOLOGY11